Fig. 2

Incidence rates of the select immune-related adverse events of nivolumab. TSH, thyroid stimulating hormone; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; GGT, γ-glutamyltransferase
Incidence rates of the select immune-related adverse events of nivolumab. TSH, thyroid stimulating hormone; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; GGT, γ-glutamyltransferase